Overview

The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants

Status:
Completed
Trial end date:
2018-05-09
Target enrollment:
Participant gender:
Summary
An Open-label, 2-period, Single-sequence, Crossover Study to Evaluate the Effect of Multiple Oral Dosing of Itraconazole on BCT197 Systemic Exposure in Healthy Male Participants.
Phase:
Phase 1
Details
Lead Sponsor:
Mereo BioPharma
Treatments:
Acumapimod
Hydroxyitraconazole
Itraconazole